Institutional Biosafety Committees (IBCs) serve as a critical linchpin in ensuring the safe and responsible conduct of research. As such they are essential in building public trust on behalf of the biomedical research enterprise. Effective June 1, 2025, and as announced on March 28, 2025: To assist institutions, NIH has revised its FAQs on IBC […]